| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8774642 | Nefrología | 2018 | 8 Pages |
Abstract
RLS showed a considerable prevalence in our HD unit. Rotigotine improved clinical symptoms, quality of life and sleep hygiene in RLS patients on HD and was found to be a safe drug with minimal side effects and total therapeutic compliance. Nevertheless, future studies should be performed to confirm the benefits of rotigotine in RLS patients on haemodialysis.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Vicent Esteve, Jose Carneiro, Gabriel Salazar, Mónica Pou, Irati Tapia, Miquel Fulquet, Verónica Duarte, Anna Saurina, Fátima Moreno, Manel RamÃrez de Arellano,